Press Releases
Press Releases
Nuron Biotech Acquires Commercial, Preventive Vaccine Meningitec™ from Pfizer
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitec™, which is a vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C. Meningitec is a preservative...
Press Releases
Organization seeks help to build clinic to fight HIV and AIDS in DR’s sugarcane plantations rural enclaves
Batey Relief Alliance (BRA) recently launched a fundraising campaign to raise US $100,000 to build a medical clinic in one of Dominican Republic's most impoverished, vulnerable and abandoned rural communities in the province Monte Plata—Batey Cinco Casas to...
Press Releases
Exact Sciences to participate in Canaccord Genuity Medical Technology & Diagnostics Forum
Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. Kevin T. Conroy, Exact’s president and chief executive, will make the company’s presentation...
Press Releases
Exact Sciences to participate in Canaccord Genuity Medical Technology & Diagnostics Forum
Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. Kevin T. Conroy, Exact’s president and chief executive, will make the company’s presentation...
Press Releases
ERYTECH Pharma Signs Licensing and Distribution Agreement with Orphan Europe for GRASPA® in Europe
ERYTECH Pharma, a late stage biopharmaceuticals company focused on orphan oncology and rare diseases, announced today that it has entered into a definitive agreement with Orphan Europe, part of the Recordati Group, granting Orphan Europe exclusive rights for...
Press Releases
Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis
Genzyme, aSanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO® (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS). The TGA approval will...
Press Releases
PerkinElmer Establishes New Direct Operations in Southern Africa to Expand Its Presence & Business in the Fast Developing Region
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has opened direct operations in Midrand, South Africa. The new PerkinElmer Southern African headquarters...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














